Tag: neureoendocrine tumors

US FDA Approves Lanreotide for Gastroenteropancreatic Neuroendocrine Tumors

Breaking News: US FDA Approves Lanreotide for Gastroenteropancreatic Neuroendocrine Tumors

December 16, 2014

December 16, 2014: The US Food and Drug Administration (FDA) today approved “lanreotide (Somatuline Depot Injection, Ipsen Pharma) for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic

READ MORE
Keith Warner, CEO, Carcinoid Cancer Foundation

Carcinoid Cancer Foundation Announces New Video Series

November 10, 2011

In recognition and support of Worldwide NET Cancer Awareness Day, the Carcinoid Cancer Foundation is pleased to announce a new video series that will begin in 2012.  This series, made possible by the generosity of Kim, Heather and Lauren Simpson and …

READ MORE